In The News
Press Releases
February 2025 – Avance Biosciences Registers with CLIA, Expanding Clinical Trial Testing Capabilities
March 2023 – Avance Biosciences licenses SeQure Dx’s GUIDE-seq off-target NGS analysis technology
May 2022 – Avance Biosciences Announces Validation of New Facilities
Feb 2022 – Mission Bio Transfers First Tapestri GMP-Ready CGT Assay to Avance Biosciences for Cell-Based Therapies
Feb 2021 – Avance Biosciences Expanding Houston Campus in Support of Cell and Gene Therapy Drug Development
Oct 2018 – Avance Biosciences Completes Successful FDA Inspection
Genetic Engineering News – June 2022
Pharma Tech Outlook – Nov 2020
Have Questions?
We are dedicated to timely, high-quality service from the start of your project to the finish. Send us a quick message with your questions to find out what Avance can do for you.
